Blood and Sputum Analysis, Learning About New Things on the Horizon
This article represents the opinions, thoughts, and experiences of the author; none of this content has been paid for by any advertiser. The Asthma.net team does not recommend or endorse any products or treatments discussed herein. Learn more about how we maintain editorial integrity here.
- Diagnosing eosinophilic asthma using a multivariate prediction model based on blood granulocyte responsiveness. Allergy. https://www.ncbi.nlm.nih.gov/pubmed/28029172#. Accessed January 21, 2017.
- Green RH, Brightling CE, McKenna S, Hargadon B, Parker D, Bradding P et al. Asthma exacerbations and sputum eosinophil counts: a randomized controlled trial. Lancet 2002; 360: 1715–1721.
- Jayaram L, Pizzichini MM, Cook RJ, Boulet L-PP, Lemière C, Pizzichini E et al. Determining asthma treatment by monitoring sputum cell counts: effect on exacerbations. Eur Respir J 2006; 27: 483–494.
- Chlumsky, Striz, Terl, Vondracek. Strategy Aimed at Reduction of Sputum Eosinophils Decreases Exacerbation Rate in Patients with Asthma. Journal of International Medical Research 2006; 34: 129139.
- Petsky HL, Cates CJ, Lasserson TJ, Li AM, Turner C, Kynaston JA et al. A systematic review and meta-analysis: tailoring asthma treatment on eosinophilic markers (exhaled nitric oxide or sputum eosinophils). Thorax 2012; 67:199–208.
- Chung KF, Wenzel SE, Brozek JL, Bush A, Castro M, Sterk PJ et al. International ERS/ATS guidelines on definition, evaluation, and treatment of severe asthma. Eur Respir J 2014; 43: 343–373.
- PubMed - NCBI. National Center for Biotechnology Information. https://www.ncbi.nlm.nih.gov/pubmed/?term=Hilvering B%5BAuthor%5D&cauthor=true&cauthor_uid=28029172. Accessed January 21, 2017.